No FDA human approval. Veterinary approval (Equipoise for horses). Limited human clinical research — primarily case reports and small studies. EPO stimulation and erythropoietic effects represent main research interest.
Testosterone derivative with double bond at C1-C2 position. Slows aromatization (~50% aromatization rate vs testosterone). Long undecylenate ester: ~14-day half-life. Notable: increases erythropoiesis via EPO stimulation — studied for anemia research. Lower androgenic profile than testosterone. Veterinary approval (horses).
~50% aromatization rate; 14-day half-life; EPO stimulation/erythropoiesis; veterinary approval only; limited human clinical data.
Research data is not a treatment plan. If you are considering Boldenone Undecylenate, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.
Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.Interactive tools for this compound:
Reconstitution calculator · Full deep dive · Peptide fundamentals